A research team has uncovered abnormal immune cell function mechanisms that may lead to Crohn’s disease. Their discovery ...

A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...

A new study published in The Journal of Immunology found that a high-salt diet (HSD) induces depression-like symptoms in mice ...

New study shows that dysfunction of protective immune cells in GI tract may contribute to onset of inflammation in Crohn's disease.

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to ...

New study shows that dysfunction of protective immune cells in GI tract may contribute to onset of inflammation in Crohn’s disease ...

IN8bio, Inc., a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies for cancer and autoimmune diseases, will participate in the Immuno-Oncology 360° Conference 2025 ...

White blood cells in the GI tract known as intraepithelial lymphocytes express the gamma delta T cell receptor (gamma delta ...

TC Biopharm shares are trading lower by 64% during Friday's session. The company announced the transition from Nasdaq to OTC ...

Researchers uncover cellular pathways linked to inflammatory bowel disease onset, offering insights for new therapies to ...

Focused on the evaluation of strategic alternativesAdopted a restructuring plan to extend capital resources, incurring a reduction in workforce ...

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today ...